Table 2 Adverse events at VAD site/trajectory per venous access device
N (%) | Inflammation | Erythema | Pain | Infection | Thrombosis | Impairment | Erosion | Extravasation | All AEa |
|---|---|---|---|---|---|---|---|---|---|
Venous access port (102) | 35 (34.3) | 30 (29.4) | 28 (27.5) | 9 (8.8) | 11 (10.8) | 5 (4.9) | 1 (1.0) | 0 (0.0) | 44 (43.1) |
Hickman line (15) | 5 (33.3) | 4 (26.7) | 4 (26.7) | 3 (20.0) | 1 (6.7) | 3 (20.0) | 0 (0.0) | 1 (6.7) | 7 (46.7) |
PICC line (10) | 5 (50.0) | 5 (50.0) | 4 (40.0) | 3 (30.0) | 2 (20.0) | 1 (10.0) | 0 (0.0) | 0 (0.0) | 5 (50.0) |
Total | 45 (35.4) | 39 (30.7) | 36 (28.3) | 15 (11.8) | 14 (11.0) | 9 (7.1) | 1 (0.8) | 1 (0.8) | 56 (44.1) |